Pembrolizumab in HER2-Positive Gastric Cancer.

ABSTRACT:

SUBMITTER: Janjigian YY 

PROVIDER: S-EPMC11620791 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature